Skip to main content
  • Radial to Femoral Access-Site Crossover in Invasive ACS Procedures Did Not Increase Risk in MATRIX Trial

    Access-site crossover from radial to femoral access in patients with acute coronary syndrome (ACS) undergoing invasive management did not appear to increase risk of major cardiovascular and clinical events in the MATRIX trial, despite a greater risk of bleeding.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details